An increase in peripheral blood progenitor cells in primates by coadministration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor

Transplantation

Volumn 64, Issue 10, 1997, Pages 1468-1473

  Suzuki, Hideki ^a,b   Ikebuchi, Kenji ^b,c   Wada, Yuka ^b   Okano, Akira ^a   Nakamiya, Teruaki ^a   Akiyama, Yukio ^a   Sawada, Takahiro ^d   Asano, Shigetaka ^b   Nakahata, Tatsutoshi ^b  

^a AJINOMOTO CO INC   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

^d N   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 6; RECOMBINANT STEM CELL FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; DRUG POTENTIATION; FEMALE; LEUKEMIA; MONKEY; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0030731159     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711270-00016     Document Type: Article

References (33)

1. Bensinger W, Singer J, Appelbaum F, et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158.
2. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21: 508.
3. Kawano Y, Takaue Y, Watanabe T, et al. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children. Exp Hematol 1993; 21: 103.
4. Suzue T, Kawano Y, Takaue Y, Kuroda Y. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor. Exp Hematol 1994; 22: 888.
5. Majolino I, Buscemi F, Scime R, et al. Treatment of normal donors with rhG-CSF 16 μg/kg for mobilization of peripheral blood stem cells and their apheretic collection for allogeneic transplantation. Haematologica 1995; 80: 219.
6. Roberts AW, Begley CG, Grigg AP, Basser RL. Do steady-state peripheral blood progenitor cell (PBSC) counts predict the yield of PBPC mobilized by filgrastim alone? Blood 1995; 86: 2451.
7. Tanaka R, Matsudaira T, Aizawa J, et al. Characterization of peripheral blood progenitor cells (PBPC) mobilized by filgrastim (rHuG-CSF) in normal volunteers: dose-effect relationship for filgrastim with the character of mobilized PBPC. Br J Haematol 1996; 92: 795.
8. Suzuki H, Okano A, Suzuki C, et al. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor. Transplantation 1995; 59: 1596.
9. Gabrilove JL, Jakubowski A, Fain K, et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988; 82: 1454.
10. Lindemann A, Herrmann F, Oster W, et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989; 74: 2644.
11. Teshima H, Ishikawa J, Kitayama H, et al. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study. Exp Hematol 1989; 17: 853.
12. Weber J, Yang JC, Topalian SL, et al. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 1993; 11: 499.
13. van Gameren MM, Willemse PHB, Mulder NH, et al. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 1994; 84: 1434.
14. D'Hondt V, Humblet Y, Guillaume T, et al. Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study. Blood 1995; 85: 2347.
15. Mayer P, Geissler K, Valent P, Ceska M, Bettelheim P, Liehl E. Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in non-human primates. Exp Hematol 1991; 19: 688.
16. Lee ME, Crawford J, Issacs R, Manfreda S, Kurtzberg J. Mobilization of peripheral blood progenitor cells with interleukin 6 + granulocyte colony-stimulating factor. Proc Am Assoc Cancer Res 1994; 35: 521.
17. Pettengell R, Luft T, de Wynter E, et al. Effects of interleukin-6 on mobilization of primitive haemopoietic cells into circulation. Br J Haematol 1995; 89: 237.
18. Yasueda H, Nagase K, Hosoda A, Akiyama Y, Yamada K. High-level direct expression of semi-synthetic human interleukin-6 of Escherichia coli and production of N-terminus Met-free product. Biotechnology 1990; 8: 1036.
19. Nakahata T, Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono-and multipotential hemopoietic progenitors. J Clin Invest 1982; 70: 1324.
20. Koike K, Nakahata T, Takagi M, et al. Synergism of BSF-2/ interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture. J Exp Med 1988; 168: 879.
21. Imai T, Koike K, Kubo T, et al. Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. Blood 1991; 78: 1969.
22. Asano S, Okano A, Ozawa K, et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 1990; 75: 1602.
23. Nieken J, Mulder NH, Buter J, et al. Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood 1995; 86: 900.
24. Brugger W, Bross K, Frish J, et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 1992; 79: 1193.
25. Elias AD, Ayash L, Anderson KC, et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036.
26. Guillaume T, D'Hondt V, Symann M. IL-3 and peripheral blood stem cell harvesting. Stem Cells 1993; 11: 173.
27. Peters WP, Rosner G, Ross M, et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709.
28. Bishop MR, Anderson JR, Jackson JD, et al. High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 1994; 83: 610.
29. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 1995; 85: 15.
30. Brasel K, McKenna HJ, Charrier K, Morrissey P, Williams DE, Lyman SD. Mobilization of peripheral blood progenitor cells with Flt3 ligand [Abstract]. Blood 1995; 86 (suppl 1): 463a.
31. Lane TA, Law P, Maruyama M, et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275.
32. Ohi S, Sakamaki S, Matsunaga T, et al. Co-administration of IL-3 with G-CSF increases the CFU-S mobilization into peripheral blood. Int J Hematol 1995; 62: 75.
33. Yan XQ, Hartley C, McElroy P, Chang A, McCrea C, McNiece I. Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice. Blood 1995; 85: 2303.